Key result
Positive SMI screening with coronary stenosis in diabetics is linked to ~400% more non-fatal cardiac events.
Why the study?
The prognosis of patients with Type 1 or Type 2 diabetes after screening for silent myocardial ischaemia was not well established.
Does positive screening for silent myocardial ischaemia predict adverse cardiac events and mortality in asymptomatic patients with diabetes?
Cohort (n=203)
Does positive screening for silent myocardial ischaemia predict adverse cardiac events and mortality in asymptomatic patients with diabetes?
Asymptomatic patients with diabetes and silent myocardial ischemia, particularly those with coronary stenosis, have a significantly higher risk of major cardiac events and mortality over 6 years.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in asymptomatic diabetes; leaves open whether screening improves outcomes.
AIMS: To determine the prognosis of patients with Type 1 or Type 2 diabetes, 6 years after screening for silent myocardial ischaemia (SMI). METHODS: Two hundred and three asymptomatic patients with diabetes underwent systematic SMI screening. From the results of this screening, they were allocated to one of three groups: patients (n = 171) with negative screening; patients (n = 32) with positive screening; and patients (n = 21) with positive screening and coronary stenosis. Six years after the initial assessment, all patients were re-assessed. All events [death, cardiac death, non-fatal major cardiac events (NFMCEs)--acute myocardial infarction, ventricular rhythm disorders, heart failure, unstable angina] were recorded. RESULTS: Fifteen patients were lost to follow-up. Patients (n = 20) with positive SMI screening and coronary stenosis had a higher risk of NFMCEs (35% vs. 7%, P < 0.001), and a higher mortality rate (35% vs. 15%, P < 0.05) compared with patients (n = 157) with negative screening. SMI-positive patients (n = 31) had a higher NFMCE rate compared with negative SMI screening patients, although overall mortality rate was no different. Cancer was the leading cause of death (36.4%). In multivariate analysis, major cardiac events (cardiac death and NFMCE) were related to baseline age, body mass index and coronary stenosis (P < 0.01). CONCLUSIONS: Patients with diabetes and SMI have a very poor prognosis as assessed by cardiac events or death, especially in the presence of coronary stenosis.
No takes yet. Share an insight, caveat, or question.
Séjil et al. (2006) conducted a cohort in Type 1 or Type 2 diabetes (n=203). Positive silent myocardial ischaemia screening with coronary stenosis vs. Negative silent myocardial ischaemia screening was evaluated on Non-fatal major cardiac events (NFMCEs) (p=<0.001). Positive screening for silent myocardial ischaemia with coronary stenosis in asymptomatic diabetic patients was associated with higher rates of non-fatal major cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: